摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-dipropylarachidonamide

中文名称
——
中文别名
——
英文名称
N,N-dipropylarachidonamide
英文别名
(5Z,8Z,11Z,14Z)-N,N-dipropylicosa-5,8,11,14-tetraenamide
N,N-dipropylarachidonamide化学式
CAS
——
化学式
C26H45NO
mdl
——
分子量
387.649
InChiKey
JVGGVUHACBVJJR-AILJCPQKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8
  • 重原子数:
    28
  • 可旋转键数:
    18
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Arachidonic acid amide inhibitors of gap junction cell-cell communication
    摘要:
    A series of arachidonic acid amides including anandamide and arachidonamide that act as potent inhibitors of the rat glial cell gap junction is described. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(99)00148-1
点击查看最新优质反应信息

文献信息

  • A METHOD OF TREATING PERIPHERAL INFLAMMATORY DISEASE
    申请人:Dublin City University
    公开号:EP3095444A1
    公开(公告)日:2016-11-23
    An active for use in the treatment or inhibition of an inflammatory disease associated with over-activation of Toll-like Receptor 4 (TLR4), Toll-like Receptor 2 (TLR2) and Myeloid differentiating protein 88 (Myd88) adaptor-like protein (Mal) while maintaining a subject's ability to respond normally to a pathogen, in which the active is an oleamide or a derivative thereof.
    一种用于治疗或抑制与Toll样受体4(TLR4)、Toll样受体2(TLR2)和髓样分化蛋白88(Myd88)适配样蛋白(Mal)过度激活相关的炎症性疾病,并同时保持受试者对病原体正常反应能力的活性物质为油酰胺或其衍生物。
  • A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE
    申请人:Dublin City University
    公开号:EP3297621A1
    公开(公告)日:2018-03-28
  • [EN] A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE<br/>[FR] PROCÉDÉ DE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE PÉRIPHÉRIQUE
    申请人:UNIV DUBLIN CITY
    公开号:WO2016185025A1
    公开(公告)日:2016-11-24
    An active for use in the treatment or inhibition of an inflammatory disease associated with over- activation of Toll-like Receptor 4 (TLR4), Toll-like Receptor 2 (TLR2) and Myeloid differentiating protein 88 (Myd88) adaptor-like protein (Ma1) while maintaining a subject's ability to respond normally to a pathogen, in which the active is an oleamide or an immunomodulatory analogue thereof.
  • Arachidonic acid amide inhibitors of gap junction cell-cell communication
    作者:Dale L. Boger、Haruhiko Sato、Aaron E. Lerner、Xiaojun Guan、Norton B. Gilula
    DOI:10.1016/s0960-894x(99)00148-1
    日期:1999.4
    A series of arachidonic acid amides including anandamide and arachidonamide that act as potent inhibitors of the rat glial cell gap junction is described. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多